Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sangamo shares in biotech spotlight
Marketwatch
Friday, February 25, 2011 - 3:44pm
tags:
Sangamo BioSciences, HIV
Dividend Report Card: Bristol-Myers Squibb
Motley Fool
Friday, February 25, 2011 - 3:43pm
tags:
dividends, Bristol-Myers Squibb
J&J Accused Of Fraud By Former Sales Manager
Pharmalot
Friday, February 25, 2011 - 8:46am
tags:
JNJ, fraud, whistleblowers
Abbott Laboratories Passes This Key Test
Motley Fool
Friday, February 25, 2011 - 8:44am
tags:
Abbott Laboratories
Pfizer, Protalix Fail to Win FDA Approval of Cerezyme Rival
Bloomberg
Friday, February 25, 2011 - 8:41am
tags:
FDA, Protalix BioTherapeutics, Pfizer, Cerezyme, taliglucerase alfa, Shire, Genzyme
Is Big Pharma Strangling Biotech Startups in Their Cradle?
The Atlantic
Friday, February 25, 2011 - 12:09am
tags:
biotech, Big Pharma, start-ups
Bristol-Myers Squibb: Outstanding Pipeline Makes It Most Attractive Among Large Pharmaceuticals
Seeking Alpha
Friday, February 25, 2011 - 12:06am
tags:
pipelines, Bristol-Myers Squibb, Reyataz, HIV, Baraclude, Orencia, rheumatoid arthritis, Sprycel, chronic myeloid leukemia, Onglyza, diabetes, hepatitis B
Amarin: Too Many Positives to Ignore
Seeking Alpha
Thursday, February 24, 2011 - 11:47pm
tags:
Amarin, AMR-101
J&J Recalls 667,632 Sudafed Packages Over Labeling Error
Bloomberg
Thursday, February 24, 2011 - 11:43pm
tags:
recalls, Sudafed, JNJ
AZ's dental unit attracts a slew of suitors
Fierce Pharma
Thursday, February 24, 2011 - 11:40pm
tags:
AstraZeneca, M&A, Astra Tech, dental
Salix Tanks After Drug Setback
Minyanville
Thursday, February 24, 2011 - 11:32pm
tags:
Salix, Xiafaxan, IBS, irritable bowel syndrome
Xenoport Expecting GERD Study Data
Seeking Alpha
Thursday, February 24, 2011 - 11:29pm
tags:
GERD, XenoPort, Horizant
Par Pharma profit rises 64 pct on lower costs
Yahoo/AP
Thursday, February 24, 2011 - 11:19pm
tags:
earnings, Par Pharmaceutical
Centocor’s $1.8B award in Remicade patent case overturned
Bizjournals.com
Thursday, February 24, 2011 - 11:18pm
tags:
Remicade, Abbott Laboratories, patents, Janssen Biotech
Lexicon Pharma's 4Q loss widens as costs rise
Yahoo/AP
Thursday, February 24, 2011 - 11:14pm
tags:
earnings, Lexicon Pharmaceuticals
Human Genome Sciences takes bigger 4Q loss
Yahoo/AP
Thursday, February 24, 2011 - 11:11pm
tags:
earnings, Human Genome Sciences
Is Novartis the Perfect Stock?
Motley Fool
Thursday, February 24, 2011 - 11:04pm
tags:
Novartis
Should You Retire With Merck?
Motley Fool
Thursday, February 24, 2011 - 5:53pm
tags:
Merck
Former Glaxo Lawyer: Name My Co-Conspirators
Pharmalot
Thursday, February 24, 2011 - 5:32pm
tags:
GSK, Wellbutrin SR, off-label, lawsuits
ViroPharma 4Q profit triples on sales
Yahoo/AP
Thursday, February 24, 2011 - 11:41am
tags:
earnings, ViroPharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.